Biologics Distributor for Medspas and Dermatology in New York, NY

Accounts require licensed, physician-supervised buyers

Precision Biologics sells only to licensed clinics, medspas operating under physician supervision, and physicians, so a New York medspa account is opened in the name of the supervising physician and verified against that physician's NPI number.

Aesthetic groups that combine a dermatology practice, a plastic surgery practice, and a medspa under common ownership can register each supervising physician and consolidate ordering once verification is complete.

What documentation to request during vendor review

A dermatology or plastic surgery practice evaluating a new biologics line typically asks for the certificate of analysis and lot release record for the specific lot, the donor eligibility summary, and, for Bio EX and Bio AER, the full ingredient disclosure covering disclosed composition.

Each lot is held in quarantine until third-party sterility testing and internal release criteria are met before it ships, which a practice can confirm through the lot release record. For exosome products specifically, Precision Biologics also points buyers to FDA's public statement that no exosome product currently carries FDA approval, so a compliance file starts from an accurate regulatory baseline.

Shipping and storage for aesthetic practices

Cryopreserved Wharton's jelly products arrive overnight on dry ice in validated containers and need -80 degree Celsius storage once unpacked, which most dermatology and plastic surgery offices can accommodate with a dedicated freezer.

Lyophilized exosome products ship shelf-stable and are reconstituted per the insert included with that lot; medspas without ultra-low freezer capacity often start with lyophilized formats for that reason. Precision Biologics asks every location to log lot numbers against patient records on receipt.

Verifying scope of practice with your state board

Scope-of-practice questions for medspas and physician-supervised aesthetic clinics in New York, including who may oversee administration of a given product, are governed by the New York State medical board and applicable supervision rules, not by Precision Biologics.

We recommend every New York aesthetic account confirm its supervision and scope arrangement with its own counsel and the state board before adding a new product category.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.